期刊
DRUG DISCOVERY TODAY
卷 19, 期 2, 页码 126-132出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2013.06.003
关键词
-
资金
- Spanish Ministry of Science and Innovation [BIO2011-27069]
- GVA-FEDER [PROMETEO/2010/001]
The popularization of genomic high-throughput technologies is causing a revolution in biomedical research and, particularly, is transforming the field of drug discovery. Systems biology offers a framework to understand the extensive human genetic heterogeneity revealed by genomic sequencing in the context of the network of functional, regulatory and physical protein-drug interactions. Thus, approaches to find biomarkers and therapeutic targets will have to take into account the complex system nature of the relationships of the proteins with the disease. Pharmaceutical companies will have to reorient their drug discovery strategies considering the human genetic heterogeneity. Consequently, modeling and computational data analysis will have an increasingly important role in drug discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据